Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status

BACKGROUND AND OBJECTIVE: Pemetrexed have been approved for the treatment of patients affected by advanced non-small cell lung cancner (NSCLC) in progression after first-line chemotherapy. We evaluated the activity and feasibility of pemetrexed in previously treated NSCLC. METHODS: Patients with his...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Young JUNG, Su, Jin YOO, Ji, Young SHIN, Ji, Won PARK, Jeong, Eun LEE, Hee, Sun PARK, Ju, Ock KIM, Sun, Young KIM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999695/
https://www.ncbi.nlm.nih.gov/pubmed/21219829
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999695/
https://www.ncbi.nlm.nih.gov/pubmed/21219829
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.07

Ejemplares similares